These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 23834691)

  • 1. Multimarker approach for identifying and documenting mitigation of cardiovascular risk.
    Penn MS; Klemes AB
    Future Cardiol; 2013 Jul; 9(4):497-506. PubMed ID: 23834691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of cardiovascular disease events.
    Wilson PW
    Cardiol Clin; 2011 Feb; 29(1):1-13. PubMed ID: 21257097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putting it into perspective: multimarker panels for cardiovascular disease risk assessment.
    Taqui S; Daniels LB
    Biomark Med; 2013 Apr; 7(2):317-27. PubMed ID: 23547825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple biomarkers for the prediction of first major cardiovascular events and death.
    Wang TJ; Gona P; Larson MG; Tofler GH; Levy D; Newton-Cheh C; Jacques PF; Rifai N; Selhub J; Robins SJ; Benjamin EJ; D'Agostino RB; Vasan RS
    N Engl J Med; 2006 Dec; 355(25):2631-9. PubMed ID: 17182988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI.
    Roubille F; Samri A; Cornillet L; Sportouch-Dukhan C; Davy JM; Raczka F; Gervasoni R; Pasquie JL; Cung TT; Piot C; Macia JC; Cransac F; Leclercq F
    Eur J Intern Med; 2010 Apr; 21(2):131-6. PubMed ID: 20206886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein: a novel marker of cardiovascular risk.
    Shah SH; Newby LK
    Cardiol Rev; 2003; 11(4):169-79. PubMed ID: 12852794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score.
    Eurlings LW; Sanders-van Wijk S; van Kimmenade R; Osinski A; van Helmond L; Vallinga M; Crijns HJ; van Dieijen-Visser MP; Brunner-La Rocca HP; Pinto YM
    J Am Coll Cardiol; 2012 Oct; 60(17):1668-77. PubMed ID: 23021334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of Canadian primary care physicians towards cardiovascular risk assessment and lipid management.
    Gupta M; Singh N; Tsigoulis M; Kajil M; Hirjikaka S; Quan A; Teoh H; Verma S
    Can J Cardiol; 2012; 28(1):14-9. PubMed ID: 22264843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the Limits: Clinical Utility of Novel Cardiac Biomarkers.
    Janković R; Marković D; Savić N; Dinić V
    Biomed Res Int; 2015; 2015():187384. PubMed ID: 26504786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
    Koenig W
    Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating biomarkers.
    Badimon L; Romero JC; Cubedo J; Borrell-Pagès M
    Thromb Res; 2012 Oct; 130 Suppl 1():S12-5. PubMed ID: 23026650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study.
    von Eynatten M; Breitling LP; Roos M; Baumann M; Rothenbacher D; Brenner H
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2327-35. PubMed ID: 22679309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.
    Ingelsson E; Pencina MJ; Tofler GH; Benjamin EJ; Lanier KJ; Jacques PF; Fox CS; Meigs JB; Levy D; Larson MG; Selhub J; D'Agostino RB; Wang TJ; Vasan RS
    Circulation; 2007 Aug; 116(9):984-92. PubMed ID: 17698726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for cardiovascular risk assessment.
    Wolfert RL
    MLO Med Lab Obs; 2009 May; 41(5):14-6. PubMed ID: 19526891
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Damman P; Kuijt WJ; Woudstra P; Haeck JD; Koch KT; Gu YL; van Straalen JP; Fischer J; Tijssen JG; Krucoff MW; de Winter RJ
    Am Heart J; 2012 May; 163(5):783-9. PubMed ID: 22607855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel cardiac markers.
    Alder R
    Adv Nurse Pract; 2009 Jun; 17(6):24-7; quiz 28. PubMed ID: 20000180
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple biomarkers and cardiovascular risk.
    Pfister R; Hellmich M
    N Engl J Med; 2008 Aug; 359(7):760; author reply 761. PubMed ID: 18703482
    [No Abstract]   [Full Text] [Related]  

  • 19. Do novel biomarkers add to existing scores of total cardiovascular risk?
    De Backer G; Graham I; Cooney MT
    Eur J Prev Cardiol; 2012 Aug; 19(2 Suppl):14-7. PubMed ID: 22801065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
    Bodí V; Sanchis J; Llàcer A; Fácila L; Núñez J; Pellicer M; Bertomeu V; Ruiz V; Chorro FJ
    Am Heart J; 2005 Feb; 149(2):268-74. PubMed ID: 15846264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.